These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36213324)

  • 101. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer.
    Chen Z; Xu P; Wang X; Li Y; Yang J; Xia Y; Wang S; Liu H; Xu Z; Li Z
    Cancer Lett; 2023 Jul; 565():216235. PubMed ID: 37209945
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer.
    Mao D; Zhou Z; Chen H; Liu X; Li D; Chen X; He Y; Liu M; Zhang C
    Cancer Lett; 2023 Sep; 572():216351. PubMed ID: 37591356
    [TBL] [Abstract][Full Text] [Related]  

  • 103. THADA inhibits autophagy and increases 5-FU sensitivity in gastric cancer cells via the PI3K/AKT/mTOR signaling pathway.
    Lin X; Pan J; Hamoudi H; Yu J
    Iran J Basic Med Sci; 2024; 27(2):195-202. PubMed ID: 38234670
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A combined analysis of bulk and single-cell sequencing data reveals that depleted extracellular matrix and enhanced immune processes co-contribute to fluorouracil beneficial responses in gastric cancer.
    Dong S; Zhang S; Zhao P; Lin G; Ma X; Xu J; Zhang H; Hu J; Zou C
    Front Immunol; 2022; 13():999551. PubMed ID: 36189263
    [TBL] [Abstract][Full Text] [Related]  

  • 105. PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer.
    Huang W; Han Z; Sun Z; Feng H; Zhao L; Yuan Q; Chen C; Yu S; Hu Y; Yu J; Liu H; Li G; Jiang Y
    Cell Death Dis; 2022 Jul; 13(7):658. PubMed ID: 35902562
    [TBL] [Abstract][Full Text] [Related]  

  • 106. The mechanism of RGS5 regulating gastric cancer mismatch repair protein.
    Yang Z; Zhang R; Liu J; Tian S; Zhang H; Zeng L; Zhang Y; Gao L; Wang M; Shan W; Liu J
    Mol Carcinog; 2024 Sep; 63(9):1750-1767. PubMed ID: 38860604
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer Patients.
    Pinto MP; Muñoz-Medel M; Retamal IN; Bravo M; Latapiat V; Córdova-Delgado M; Hill CN; Fernández MF; Sánchez C; Sáez MA; Martin AJM; Morales-Pison S; Fernandez-Ramires R; García-Bloj B; Owen GI; Garrido M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613445
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
    Lin C; Lin P; Yao H; Liu S; Lin X; He R; Teng Z; Zuo X; Li Y; Ye J; Zhu G
    Cancer Lett; 2024 Apr; 587():216712. PubMed ID: 38364962
    [TBL] [Abstract][Full Text] [Related]  

  • 109. HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer.
    Suo D; Gao X; Chen Q; Zeng T; Zhan J; Li G; Zheng Y; Zhu S; Yun J; Guan XY; Li Y
    J Exp Clin Cancer Res; 2024 Apr; 43(1):106. PubMed ID: 38589927
    [TBL] [Abstract][Full Text] [Related]  

  • 110. SP1 Mediated PIK3CB Upregulation Promotes Gastric Carcinogenesis.
    Fan K; Hu Q; Yu S; Gao Y; Li Y
    J Cancer; 2024; 15(5):1355-1365. PubMed ID: 38356702
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Cisplatin-Resistant Gastric Cancer Cells Promote the Chemoresistance of Cisplatin-Sensitive Cells via the Exosomal RPS3-Mediated PI3K-Akt-Cofilin-1 Signaling Axis.
    Sun MY; Xu B; Wu QX; Chen WL; Cai S; Zhang H; Tang QF
    Front Cell Dev Biol; 2021; 9():618899. PubMed ID: 33644057
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance.
    Reyes ME; Pulgar V; Vivallo C; Ili CG; Mora-Lagos B; Brebi P
    Front Immunol; 2024; 15():1347530. PubMed ID: 38455038
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies.
    Li Y; Xu C; Wang B; Xu F; Ma F; Qu Y; Jiang D; Li K; Feng J; Tian S; Wu X; Wang Y; Liu Y; Qin Z; Liu Y; Qin J; Song Q; Zhang X; Sujie A; Huang J; Liu T; Shen K; Zhao JY; Hou Y; Ding C
    Nat Commun; 2022 Sep; 13(1):5723. PubMed ID: 36175412
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Epigenetic Modification-Associated Molecular Classification of Gastric Cancer.
    Zeng W; Zhu J; Zeng D; Guo J; Huang G; Zeng Y; Wang L; Bin J; Liao Y; Shi M; Liao W
    Lab Invest; 2023 Sep; 103(9):100170. PubMed ID: 37150296
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer.
    Weng S; Li M; Deng J; Xu H; Ren Y; Zhou Z; Wang L; Zhang Y; Xing Z; Li L; Liu Z; Han X
    Clin Epigenetics; 2023 Apr; 15(1):64. PubMed ID: 37061743
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy.
    Huh YJ; Cho SY; Cho MS; Lee KE; Lee JH
    Genes Genomics; 2022 Nov; 44(11):1425-1435. PubMed ID: 35622232
    [TBL] [Abstract][Full Text] [Related]  

  • 117. RUNDC3A/SNAP25/Akt signaling mediates tumor progression and chemoresistance in gastric neuroendocrine carcinoma.
    Lin Z; Kwok HF
    Cell Death Dis; 2022 Oct; 13(10):840. PubMed ID: 36182960
    [TBL] [Abstract][Full Text] [Related]  

  • 118. A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer.
    Gupta J; Ahmed AT; Tayyib NA; Zabibah RS; Shomurodov Q; Kadheim MN; Alsaikhan F; Ramaiah P; Chinnasamy L; Samarghandian S
    Biomed Pharmacother; 2023 Oct; 166():115337. PubMed ID: 37659203
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancer.
    Liu Q; Lian Q; Song Y; Yang S; Jia C; Fang J
    Front Oncol; 2023; 13():1119945. PubMed ID: 37007092
    [TBL] [Abstract][Full Text] [Related]  

  • 120. HIST1H2BK predicts neoadjuvant-chemotherapy response and mediates 5-fluorouracil resistance of gastric cancer cells.
    Chen Z; Tang X; Li W; Li T; Huang J; Jiang Y; Qiu J; Huang Z; Tan R; Ji X; Lv L; Yang Z; Chen H
    Transl Oncol; 2024 Aug; 46():102017. PubMed ID: 38852277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.